Tapewire

NYSE · USD

FLS

FLOWSERVE CORP

Export transactions ↓
Tapewire entity
3541
SEC CIK
0000030625
Parsed reports
537

Last 12 months

Inside the activity.

2 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2026 Filed Feb 17, 2026 21:36 UTC
Duhon Lamar L.President, FPD
Tax withholdingCommon Stock 10,346 $87.02 $900,308.92
Disclosure

SEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · nonDerivative · entry 2

Duhon Lamar L. · CIK 0001904002 · President, FPD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,916

Read SEC document
February 13, 2026 Filed Feb 17, 2026 21:36 UTC
Duhon Lamar L.President, FPD
GrantCommon Stock 26,146 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · nonDerivative · entry 1

Duhon Lamar L. · CIK 0001904002 · President, FPD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,262

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Rowe Robert ScottDirector · President & CEO
GrantRestricted Stock Units · Derivative 38,022 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008632 · wk-form4_1771364251.xml · derivative · entry 4

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,976

Underlying: Common Stock · 38,022 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Rowe Robert ScottDirector · President & CEO
GrantPerformance Rights · Derivative 57,034 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008632 · wk-form4_1771364251.xml · derivative · entry 3

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,196

Underlying: Common Stock · 57,034 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
VOPNI SCOTT KChief Accounting Officer
GrantRestricted Stock Units · Derivative 2,941 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008633 · wk-form4_1771364257.xml · derivative · entry 2

VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,230

Underlying: Common Stock · 2,941 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
VOPNI SCOTT KChief Accounting Officer
GrantPerformance Rights · Derivative 1,260 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008633 · wk-form4_1771364257.xml · derivative · entry 1

VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,105

Underlying: Common Stock · 1,260 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Schwetz Amy BChief Financial Officer
GrantRestricted Stock Units · Derivative 14,892 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008631 · wk-form4_1771364245.xml · derivative · entry 4

Schwetz Amy B · CIK 0001647437 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,431

Underlying: Common Stock · 14,892 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Schwetz Amy BChief Financial Officer
GrantPerformance Rights · Derivative 14,892 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008631 · wk-form4_1771364245.xml · derivative · entry 3

Schwetz Amy B · CIK 0001647437 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,103

Underlying: Common Stock · 14,892 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Hudson Susan ClaireChief Legal Officer
GrantRestricted Stock Units · Derivative 7,287 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008629 · wk-form4_1771364229.xml · derivative · entry 4

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,315

Underlying: Common Stock · 7,287 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Hudson Susan ClaireChief Legal Officer
GrantPerformance Rights · Derivative 7,287 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008629 · wk-form4_1771364229.xml · derivative · entry 3

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,981

Underlying: Common Stock · 7,287 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
DeBiasio Alice MariePresident, FCD
GrantRestricted Stock Units · Derivative 5,703 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008630 · wk-form4_1771364237.xml · derivative · entry 2

DeBiasio Alice Marie · CIK 0002091999 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,216

Underlying: Common Stock · 5,703 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
DeBiasio Alice MariePresident, FCD
GrantPerformance Rights · Derivative 5,703 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008630 · wk-form4_1771364237.xml · derivative · entry 1

DeBiasio Alice Marie · CIK 0002091999 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,703

Underlying: Common Stock · 5,703 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Boukalik BrianChief Human Resources Officer
GrantRestricted Stock Units · Derivative 5,069 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008628 · wk-form4_1771364221.xml · derivative · entry 2

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,156

Underlying: Common Stock · 5,069 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:37 UTC
Boukalik BrianChief Human Resources Officer
GrantPerformance Rights · Derivative 5,069 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008628 · wk-form4_1771364221.xml · derivative · entry 1

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,055

Underlying: Common Stock · 5,069 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:36 UTC
Duhon Lamar L.President, FPD
GrantRestricted Stock Units · Derivative 9,505 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · derivative · entry 4

Duhon Lamar L. · CIK 0001904002 · President, FPD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,082

Underlying: Common Stock · 9,505 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:36 UTC
Duhon Lamar L.President, FPD
GrantPerformance Rights · Derivative 9,505 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · derivative · entry 3

Duhon Lamar L. · CIK 0001904002 · President, FPD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,090

Underlying: Common Stock · 9,505 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
February 11, 2026 Filed Feb 12, 2026 21:17 UTC GrantPhantom Stock · Derivative 839 $87.37 $73,303.43
Disclosure

SEC source: 0001628280-26-007692 · wk-form4_1770931022.xml · derivative · entry 1

GARRISON JOHN L JR · CIK 0001656422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,041

Underlying: Common Stock · 839 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
February 11, 2026 Filed Feb 12, 2026 21:16 UTC GrantPhantom Stock · Derivative 69 $87.37 $6,028.53
Disclosure

SEC source: 0001628280-26-007691 · wk-form4_1770931016.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,193

Underlying: Common Stock · 69 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
February 11, 2026 Filed Feb 12, 2026 21:16 UTC GrantPhantom Stock · Derivative 345 $87.37 $30,142.65
Disclosure

SEC source: 0001628280-26-007690 · wk-form4_1770931010.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,233

Underlying: Common Stock · 345 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
February 02, 2026 Filed Feb 3, 2026 21:25 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 84 $78.15 $6,564.60
Disclosure

SEC source: 0001628280-26-005036 · wk-form4_1770153927.xml · nonDerivative · entry 1

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,714

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in a prescheduled transaction.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:23 UTC
Rowe Robert ScottDirector · President & CEO
Exercise / conversionStock Option · Derivative 114,943 $0.00 Strike: $48.63 $0.00
Disclosure

SEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · derivative · entry 5

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 114,943 shares

Expires 2027-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested on April 1, 2020.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:23 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 2,517 $70.92 $178,505.64
Disclosure

SEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 4

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,630

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.92 to $70.95. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:23 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 95,223 $70.39 $6,702,746.97
Disclosure

SEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 3

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,147

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $69.92 to $70.91. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:23 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 114,943 $70.54 $8,108,079.22
Disclosure

SEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 2

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,370

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.27 to $70.91. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:23 UTC
Rowe Robert ScottDirector · President & CEO
Exercise / conversionCommon Stock 114,943 $48.63 $5,589,678.09
Disclosure

SEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 1

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559,313

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2025 Filed Dec 1, 2025 22:15 UTC GiftCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-054495 · wk-form4_1764627309.xml · nonDerivative · entry 1

DELLY GAYLA J · CIK 0001218358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,496

F1 · shares: On December 1, 2025, the reporting person made a charitable gift of 900 shares of Common Stock. No shares were sold.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 21:04 UTC GiftCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-053975 · wk-form4_1764104648.xml · nonDerivative · entry 1

DELLY GAYLA J · CIK 0001218358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,396

F1 · shares: On November 24, 2025, the reporting person made a charitable gift of 600 shares of Common Stock. No shares were sold.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:49 UTC GrantPhantom Stock · Derivative 530 $69.27 $36,713.10
Disclosure

SEC source: 0001628280-25-052105 · wk-form4_1763070553.xml · derivative · entry 1

GARRISON JOHN L JR · CIK 0001656422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,202

Underlying: Common Stock · 530 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:49 UTC GrantPhantom Stock · Derivative 435 $69.27 $30,132.45
Disclosure

SEC source: 0001628280-25-052104 · wk-form4_1763070545.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 435 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:49 UTC GrantPhantom Stock · Derivative 435 $69.27 $30,132.45
Disclosure

SEC source: 0001628280-25-052103 · wk-form4_1763070539.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,888

Underlying: Common Stock · 435 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:48 UTC GrantPhantom Stock · Derivative 87 $69.27 $6,026.49
Disclosure

SEC source: 0001628280-25-052102 · wk-form4_1763070533.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,124

Underlying: Common Stock · 87 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 02:38 UTC
Duhon Lamar L.President, FPD
SaleCommon Stock 1,609 $69.51 $111,841.59
Disclosure

SEC source: 0001628280-25-051805 · wk-form4_1763001498.xml · nonDerivative · entry 1

Duhon Lamar L. · CIK 0001904002 · President, FPD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,116

Read SEC document
November 04, 2025 Filed Nov 5, 2025 22:13 UTC
Schwetz Amy BChief Financial Officer
SaleCommon Stock 47,000 $71.02 $3,337,940.00
Disclosure

SEC source: 0001628280-25-049691 · wk-form4_1762380814.xml · nonDerivative · entry 1

Schwetz Amy B · CIK 0001647437 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,628

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $71.00 to $71.06. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 04, 2025 Filed Nov 5, 2025 22:12 UTC
Hudson Susan ClaireChief Legal Officer
SaleCommon Stock 10,667 $70.01 $746,796.67
Disclosure

SEC source: 0001628280-25-049688 · wk-form4_1762380723.xml · nonDerivative · entry 1

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,589

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.00 to $70.08. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 28, 2025 Filed Oct 29, 2025 21:36 UTC
DeBiasio Alice MariePresident, FCD
GrantRestricted Stock Units · Derivative 13,513 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-047200 · wk-form4_1761773762.xml · derivative · entry 1

DeBiasio Alice Marie · CIK 0002091999 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,513

Underlying: Common Stock · 13,513 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
October 01, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 18 $53.14 $956.52
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 11

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,332

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
September 02, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 26 $53.66 $1,395.16
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 10

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,314

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
August 12, 2025 Filed Aug 12, 2025 20:24 UTC
Wilson KirkPresident, FCD
SaleCommon Stock 10,000 $53.22 $532,200.00
Disclosure

SEC source: 0001654776-25-000004 · wk-form4_1755030262.xml · nonDerivative · entry 1

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,196

F1 · shares: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.20 to $53.26, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 08, 2025 Filed Aug 11, 2025 21:28 UTC
Wilson KirkPresident, FCD
SaleCommon Stock 10,000 $52.58 $525,800.00
Disclosure

SEC source: 0001628280-25-039651 · wk-form4_1754947694.xml · nonDerivative · entry 1

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,196

F1 · shares: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.56 to $52.62, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
August 01, 2025 Filed Nov 3, 2025 23:06 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 10 $56.04 $560.40
Disclosure

SEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 9

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,370

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
August 01, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 16 $56.04 $896.64
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 9

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,288

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:29 UTC GrantPhantom Stock · Derivative 540 $55.95 $30,213.00
Disclosure

SEC source: 0001628280-25-036737 · wk-form4_1753907385.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,453

Underlying: Common Stock · 540 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:32 UTC GrantPhantom Stock · Derivative 107 $55.95 $5,986.65
Disclosure

SEC source: 0001628280-25-036741 · wk-form4_1753907547.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,037

Underlying: Common Stock · 107 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:28 UTC GrantPhantom Stock · Derivative 540 $55.95 $30,213.00
Disclosure

SEC source: 0001628280-25-036735 · wk-form4_1753907286.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,065

Underlying: Common Stock · 540 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:25 UTC GrantPhantom Stock · Derivative 830 $55.95 $46,438.50
Disclosure

SEC source: 0001628280-25-036732 · wk-form4_1753907149.xml · derivative · entry 1

GARRISON JOHN L JR · CIK 0001656422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,672

Underlying: Common Stock · 830 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
July 01, 2025 Filed Nov 3, 2025 23:06 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 85 $52.35 $4,449.75
Disclosure

SEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 8

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,360

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
July 01, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 18 $52.35 $942.30
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 8

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,272

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:12 UTC
Boukalik BrianChief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 682 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · derivative · entry 3

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,087

Underlying: Common Stock · 682 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:12 UTC
Boukalik BrianChief Human Resources Officer
Tax withholdingCommon Stock 169 $46.46 $7,851.74
Disclosure

SEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · nonDerivative · entry 2

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,421

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:12 UTC
Boukalik BrianChief Human Resources Officer
Exercise / conversionCommon Stock 693 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · nonDerivative · entry 1

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.